BB
GSK icon

Busey Bank’s GSK GSK Stock Holding History

Busey Bank’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Sell
4,295
-606
-12% -$32K 0.01% 352
2026
Q1 		$270K Sell
4,901
-5,361
-52% -$291K 0.01% 318
2025
Q4 		$503K Sell
10,262
-343
-3% -$16K 0.01% 249
2025
Q3 		$458K Buy
10,605
+1,995
+23% +$77.9K 0.01% 250
2025
Q2 		$331K Buy
8,610
+156
+2% +$5.96K 0.01% 279
2025
Q1 		$328K Buy
8,454
+915
+12% +$33.5K 0.01% 272
2024
Q4 		$255K Sell
7,539
-107
-1% -$3.85K 0.01% 303
2024
Q3 		$313K Buy
7,646
+53
+0.7% +$2.17K 0.01% 283
2024
Q2 		$292K Sell
7,593
-1,119
-13% -$47.1K 0.01% 284
2024
Q1 		$373K Sell
8,712
-912
-9% -$37.6K 0.01% 268
2023
Q4 		$357K Sell
9,624
-165
-2% -$5.92K 0.01% 265
2023
Q3 		$355K Sell
9,789
-2,209
-18% -$78.4K 0.02% 249
2023
Q2 		$428K Hold
11,998
– – 0.02% 249
2023
Q1 		$427K Sell
11,998
-340
-3% -$11.9K 0.02% 247
2022
Q4 		$434K Sell
12,338
-303
-2% -$10.1K 0.02% 241
2022
Q3 		$372K Buy
12,641
+3,530
+39% +$134K 0.02% 253
2022
Q2 		$496K Hold
9,111
– – 0.02% 233
2022
Q1 		$496K Sell
9,111
-473
-5% -$25.7K 0.02% 246
2021
Q4 		$528K Sell
9,584
-1,115
-10% -$58K 0.02% 246
2021
Q3 		$511K Buy
10,699
+6,259
+141% +$314K 0.02% 248
2021
Q2 		$221K Buy
+4,440
New +$213K 0.01% 308
2014
Q4 		– Sell
-3,545
Closed -$204K – 211
2014
Q3 		$204K Buy
3,545
+169
+5% +$10.4K 0.03% 194
2014
Q2 		$226K Hold
3,376
– – 0.03% 182
2014
Q1 		$225K Hold
3,376
– – 0.03% 170
2013
Q4 		$225K Buy
+3,376
New +$219K 0.03% 169

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Busey Bank's GSK Position: Q2 2026 in Review

Busey Bank reduced its GSK (GSK) stake by 12% in Q2 2026, selling an estimated $32K and leaving 4,295 shares worth $225K. The position accounts for 0.01% of the portfolio, ranked #352.

Busey Bank first reported a position in GSK in Q4 2013 and has held it in 25 quarters since. The position peaked at $528K in Q4 2021. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Busey Bank held 4,295 shares of GSK worth $225K as of Q2 2026.
  • Busey Bank sold 606 GSK shares in Q2 2026, an estimated $32K.
  • GSK made up 0.01% of Busey Bank's portfolio in Q2 2026, its #352 holding.
  • Busey Bank first reported a position in GSK in Q4 2013 and has held it in 25 quarters since.
  • Busey Bank's GSK position peaked at $528K in Q4 2021.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Busey Bank's 13F filing for Q2 2026, filed 13 Aug 2026.